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Evidence has shown activation of T and B cells in gingival tissues in experimental mod-
els and in humans diagnosed with periodontitis. The results of this adaptive immune 
response are noted both locally and systemically with antigenic specificity for an array 
of oral bacteria, including periodontopathic species, e.g., Porphyromonas gingivalis and 
Aggregatibacter actinomycetemcomitans. It has been recognized through epidemiolog-
ical studies and clinical observations that the prevalence of periodontitis increases with 
age. This report describes our studies evaluating gingival tissue transcriptomes in humans 
and specifically exploiting the use of a non-human primate model of naturally occurring 
periodontitis to delineate gingival mucosal tissue gene expression profiles focusing on 
cells/genes critical for the development of humoral adaptive immune responses. Patterns 
of B cell and plasmacyte genes were altered in aging healthy gingival tissues. Substantial 
increases in a large number of genes reflecting antigen-dependent activation, B cell 
activation, B cell proliferation, and B cell differentiation/maturation were observed in peri-
odontitis in adults and aged animals. Finally, evaluation of the relationship of these gene 
expression patterns with those of various tissue destructive molecules (MMP2, MMP9, 
CTSK, TNFα, and RANKL) showed a greater frequency of positive correlations in healthy 
tissues versus periodontitis tissues, with only MMP9 correlations similar between the 
two tissue types. These results are consistent with B cell response activities in healthy 
tissues potentially contributing to muting the effects of the tissue destructive biomole-
cules, whereas with periodontitis this relationship is adversely affected and enabling a 
progression of tissue destructive events.
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inTrODUcTiOn
“Negative, age-related changes in our innate and adaptive immune 
systems are known collectively as immunosenescence. A lifetime 
of stress on our bodies is thought to contribute to immunosenes-
cence. Radiation, chemical exposure, and exposure to certain dis-
eases can also speed up the deterioration of the immune system.”1 
This general concept conveyed by the National Institute of Aging 
has been supported by a wealth of epidemiological data, which 
has laid a foundation to better understand the age-related changes 
in immune functioning that facilitate increased development of 
an array of diseases later in life. Aging is a degenerative process 
with hallmarks of chronic inflammation and oxidative stress-
related mitochondrial damage that contribute to the initiation 
of other deleterious processes within cells, including epigenetic 
modification of gene expression that can affect normal cellular 
functions (1). Alterations in both innate and adaptive immunity 
have been universally observed in aging populations and have led 
to the birth of such terms as “immune-aging” or “immunosenes-
cence” to reflect the deteriorating nature of the immune system 
(2). Studies have shown that increases in the incidence of inflam-
mation, autoimmunity, cancer, and susceptibility to infections 
in aging individuals coincide with a significant decline in host 
immunity and can negatively affect the efficacy of vaccinations 
in the elderly (3, 4).
Age-related reductions in the adaptive immune response are 
often accompanied by the presentation of a chronic low-grade 
inflammatory state, termed “inflammaging,” which can be influ-
enced both by genetic and environmental factors and contributes 
to the individual variation observed within the population 
(5). Under normal circumstances, immunoactivation is a host 
defense response that evolved to protect humans against numer-
ous pathogens. However, recent studies are showing that the 
coincident loss of normal innate and adaptive immune response 
capacity with aging, combined with low-grade chronic inflam-
mation, work together to effectively alter immunocompetence 
and promote the pathogenesis of a diverse number of diseases 
(6). These findings suggest that “unhealthy” aging is driven in 
part by the dysregulation of immunoactivation (7). Alterations 
in positive and negative feedback signaling with aging appear to 
occur with all type of cells involved in immune responses; from 
short-lived neutrophils to long-lived T lymphocytes and mac-
rophages. Recently, a review by Boraschi et al. (8) summarized 
several possible causes of immunosenescence and provided some 
strategies for counteracting this decline of immune responsive-
ness with aging.
Animal models, frequently focusing on the use of vari-
ous genetically unique strains of laboratory mice, have been 
employed to advance our knowledge of aging and will continue 
to be useful tools. These types of studies can address many of 
the basic questions pertaining to the molecular regulation and/
or dysregulation of the immune response and increased inflam-
mation that accompanies aging. More recent studies have utilized 
1 http://www.nia.nih.gov/health/publication/biology-aging/immune- system-can- 
your-immune-system-still-defend-you-you-age
these approaches in rodents to examine the impact of aging on 
periodontitis, and generally supported an increase in disease 
with aging (9–11). However, there are many fundamental differ-
ences in the basic immunology of mice and humans, particularly 
with respect to the microbiome composition, characteristics of 
immune cell transcriptional regulators, and receptors utilized 
for engaging pathogens and commensal bacteria, as well as the 
types of environmental stressors. Moreover, the rodent model has 
generally focused on the potential role of individual molecules 
within complex pathways in attempting to explain susceptibil-
ity or resistance to disease (12–16). These studies generally do 
not address the biology of the system that will be necessary to 
clearly define the multivariate changes that occur with healthy 
and diseased aging (2). Thus, Franceschi et al. (17) have proposed 
a “network theory of aging” emphasizing a broad reduction in 
the ability of the host response systems to cope with the array 
of challenges in concert with a progressing intrinsic proinflam-
matory environment that accompanies the aging process. These 
concepts emphasize a remaining need for sophisticated and 
detailed documentation of the human or human-like models of 
aging and immunosenescence (17).
While substantial emphasis has been placed on studies of innate 
immune and inflammatory responses in chronic periodontitis 
over the decades (18), extensive findings have described local and 
systemic antibody responses that (i) react with certain bacteria 
(19–21), (ii) increase with periodontitis, and (iii) are altered by 
treatment (22). Examination of the gingival tissue transcriptome 
in various studies have either “cast a broad net” to identify the 
multitude of differences between health and disease (23–27) or 
focused on innate immune response molecules (28–31). This 
article describes our ongoing studies focusing on the use of a non-
human primate model of periodontitis to explore the response 
environment in the gingival mucosal tissues. We spotlight in this 
report on cellular markers of humoral adaptive immunity related 
to aging and chronic inflammatory disease of the oral mucosa 
and alveolar bone.
Various discussions regarding the role of adaptive immunity, 
and particularly humoral immune responses in the development 
of, or protection from, periodontitis have occurred over the 
decades, with some consistency in findings regarding antibody 
levels increased with disease (20, 22); however, severe general-
ized disease may show some decreased antibody levels (32–35). 
Treatment of periodontal disease usually associated with early 
increases but long-term decreases with successful therapy in 
antibody specific for oral bacteria (36–40). Animals models have 
also demonstrated the potential for antigen-specific T and B cells 
to exacerbate local disease (41–43), whereas active immunization 
has demonstrated protection from induced disease (16, 44–47).
MaTerials anD MeThODs
human gingival samples
Gingival tissue samples were obtained from three healthy and 
four periodontitis patients following Institutional Review Board 
approval and patient consent to utilize discarded tissues from 
standard of care surgical therapy for periodontitis and impacted 
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third molar removal. Healthy tissues were uninflamed obtained 
from third molar extractions, patients aged 25–36  years, 66% 
females. The periodontitis samples were obtained via surgical 
therapy from sites with pocket depth ≥6 mm and radiographic 
evidence of alveolar bone loss, aged 32–51 years, 50% females. 
The samples were obtained and placed into chilled buffer. Total 
RNA was isolated from each gingival tissue specimen using 
TRIzol reagent following the protocol recommended by the 
manufacturer (Invitrogen, Indianapolis, IN, USA). The extracted 
RNA was cleaned up using the Qiagen RNeasy mini kit (Qiagen, 
Valencia, CA, USA) and quantified using spectrophotometric 
analysis. RNA from each sample was reverse transcribed and 
hybridized to the GeneChip® HT Human Genome U133 Plus 2.0 
Array (Affymetrix, Santa Clara, CA, USA) similar to methods 
we have described previously. Probe arrays were scanned using 
GeneChip Scanner 3000 for high resolution scanning and 
GeneChip Operating Software MAS 5.0.
non-human Primate experimental Design
Rhesus monkeys (Macaca mulatta) (n = 34; 14 females and 20 
males) housed at the Caribbean Primate Research Center (CPRC) 
at Sabana Seca, PR, USA, were used in these studies. A cross-
sectional study of healthy and naturally occurring periodontitis 
(48) animals were categorized as: young healthy (≤3 years; n = 5), 
adolescent healthy (3–7 years; n = 5), adults (12–16 years) healthy 
(n = 7) and periodontitis (n = 5), and aged (18–23 years) healthy 
(n = 6) and periodontitis (n = 6). The non-human primates were 
typically fed a 20% protein, 5% fat, and 10% fiber commercial 
monkey diet (diet 8773, Teklad NIB primate diet modified: Harlan 
Teklad). The diet was supplemented with fruits and vegetables, 
and water was provided ad libitum in an enclosed corral setting.
A protocol approved by the Institutional Animal Care and Use 
Committee (IACUC) of the University of Puerto Rico, enabled 
anesthetized animals to be examined for clinical measures of 
periodontal health, including probing pocket depth (PPD), and 
bleeding on probing (BOP) as we have described previously 
(49). Naturally occurring periodontitis sites were defined as PPD 
≥4 mm and BOP ≥1.
Microarray analyses
A buccal gingival sample from either healthy or periodontitis-
affected tissue from the premolar/molar maxillary region 
of each animal was taken using a standard gingivectomy 
technique, and maintained frozen in RNAlater solution. Total 
RNA was isolated from each gingival tissue using a standard 
procedure as we have described, and tissue RNA samples sub-
mitted to the microarray core to assess RNA quality analyze the 
transcriptome using the GeneChip® Rhesus Macaque Genome 
Array (Affymetrix) (48, 50). Individual samples were used for 
gene expression analyses.
statistical analyses
Normalization of values across the chips was accomplished 
through signal intensity standardization across each chip using 
Affymetrix PLIER algorithm. The arrays contained matched and 
mismatched pairs allowing the MAS 5 algorithm to be used. For 
each gene, we first determined differences in expression across 
the groups using ANOVA (Version 9.3, SAS Inc., Cary, NC, 
USA). The healthy aged tissues were then compared with the 
other age groups using a t-test and accepting a p-value ≤0.05 for 
significance. Because of the cost of these types of non-human 
primate experiments and availability of primates of the various 
ages, we did not have sufficient samples to identify if the relation-
ship between age and gene expression could be treated using a 
linear model; thus, the subjects were classified, and ANOVA was 
used for analysis. The choice of Least Significant Difference for 
multiple comparisons (ANOVA followed by t-tests) provided 
maximum power given our necessarily small sample sizes. We 
determined a correlation with aging in healthy tissues using 
a Spearman Rank correlation analysis that was fit to the gene 
expression by age. A p-value ≤0.05 was used to evaluate the 
significance of the correlation. Volcano plots were prepared to 
visualize outlier gene expression profiles in the aging animals 
compared with the other age group (51). The heat maps with 
hierarchical clusters were prepared using MeV_4_9_0 (open 
source genomic analysis software).2 These data have been 
uploaded into the ArrayExpress data base3 under accession 
number: E-MTAB-1977.
resUlTs
gingival Transcriptome alterations in 
aging and Periodontitis
While reports have documented the end result of adaptive 
immune cell functions, i.e., antibody, rather sparse informa-
tion is available regarding the cellular changes that occur in 
the periodontitis gingival tissues with respect to the adaptive 
immune response. Figure  1 provides volcano plots depicting 
the characteristics of gene expression differences in healthy 
and naturally occurring periodontitis tissues from humans and 
non-human primates. This profile provides a depiction of the 
magnitude of change in each gene (i.e., Fold Δ) and the level 
of significant difference (i.e., p-value) in each gene comparing 
periodontitis to healthy tissues. Table 1 summarizes the identi-
fication of the top 50 upregulated genes in periodontitis gingival 
tissues from humans and non-human primates compared with 
healthy gingiva. The interesting aspect of these findings was that 
of the top 50 upregulated expressed genes in periodontitis tis-
sues from humans and the non-human primates 40–60% were 
representative of genes that would affect the adaptive immune 
response including antigen presentation and processing, B and 
T cell regulation, and regulation of immunoglobulin charac-
teristics. These findings support an active role in the complex 
gingival environment of established periodontitis lesions for 
the adaptive immune response. Whether this response profile 
is a hallmark for the development and expression of a protec-
tive immune response remains unclear in human disease (20, 
22, 52). Furthermore, the effects of aging on these patterns of 
responses remain understudied.
2 www.tm4.org
3 www.ebi.ac.uk
A B
FigUre 1 | Volcano plots of gene expression in human gingival tissues (a) and non-human primate gingival tissues (B) comparing levels in 
periodontitis tissues from healthy tissues. Human samples (n = 3 healthy; n = 4 periodontitis) and non-human primate samples [n = 13 healthy; n = 11 
periodontitis (adults and aged)] were tested. The graphs displays a point for the expression of each gene in periodontitis versus healthy tissues plotted as log2 fold 
difference (Δ) and −log10 p-value significance versus healthy tissues. The vertical red dashed lines signify a fold difference in expression at twofold and the horizontal 
red dashed line signifies a significant difference of p < 0.01.
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B cell- and Plasmacyte-associated 
Transcriptome in aging and Periodontitis
To evaluate alterations in B cell development and maturation 
in the gingival tissue, we documented expression of 190 genes 
that are associated with B cell and plasmacyte development and 
functions. We also categorized the B cell genes into those related 
to B cell activation, proliferation, and differentiation, as well as 
antigen-stimulated activation of these cells. The plasmacyte genes 
were related to general cellular expression and those suggested 
to be altered in early or mature plasmacytes. Figure  2A is a 
diagrammatic representation of altered gene expression profiles 
in healthy gingival tissues from young, adolescent, and aged 
animals compared with levels in healthy adult tissues. The results 
show that 31 genes are expressed at higher levels in the healthy 
aged tissues, whereas only 1 and 5 were elevated in young and 
adolescent healthy gingiva compared with healthy adult tissues. 
The figure also demonstrates that all gene changes in the young 
and adolescent overlapped with the changes in aged tissues. In 
contrast, only 2 of this gene set were downregulated in healthy 
aging tissues, whereas 19 were significantly decreased in young 
and 15 in adolescent tissues with approximately 50% overlapping. 
Figure 2B presents an overview of the prevalence of genes that 
were up- or downregulated in periodontitis in the adult or aged 
animals (naturally occurring periodontitis does not present in the 
younger animal groups). The results showed that two times more 
genes were upregulated in aged periodontitis tissues compared 
with the adult group. Approximately 90% of the elevated genes 
in adult periodontitis tissues were also elevated in the aging 
tissues. In contrast, very few genes were downregulated with 
periodontitis in either age group, with only about 1/2 of these 
genes overlapping in the two age groups.
We then examined the characteristics of these altered genes 
related to B cell functions. Table 2 summarizes these alterations 
in healthy tissues of each of the age groups compared with levels 
in healthy adult tissues. The majority of gene expression changes 
in the healthy tissues were associated with antigen-dependent 
activation and B cell differentiation/maturation processes (26.3 
and 37.9%, respectively). As was noted in the Venn diagrams, 
the majority of the gene changes were elevations in aged healthy 
tissues across all functional groups.
Figures 3A–G provide the results of gene expression changes 
in the various functional categories related to periodontitis in 
adults and aged animals, as well as a summary of all periodontitis 
samples. With the antigen-dependent activation genes, 21 out of 
38 were altered with periodontitis, generally being increased in 
both age groups, and most often with fold increases greatest in 
the aged group. Only CD274 (programed death-ligand 1 with a 
major role in suppressing the immune system through a signal 
that inhibits TCR-mediated activation of IL-2 production and T 
cell proliferation) and ID3 (DNA-binding protein inhibitor ID-3 
is a transcription inhibitor) were decreased with periodontitis. B 
cell activation genes were altered (8/18) with periodontitis, again 
showing higher fold increases in the aged tissues. Approximately 
14/33 B cell proliferation-related genes were altered with 
periodontitis in both adults and aged animals. Of these, only 
BCL2L1 (potent inhibitor of cell death by inhibiting activation 
of caspases) and FLT3 (Fms-like tyrosine kinase 3 or CD135 
is important or lymphocyte development) were consistently 
decreased. Examination of the B cell differentiation/maturation 
genes showed 32/58 were altered in periodontitis (Figures 3D,E). 
Again the highest fold increases were in the aged tissue samples. 
Interestingly, one-third of these genes were associated with genes 
TaBle 1 | identification of the top 50 upregulated genes in periodontitis 
versus healthy gingival tissues related to adaptive immune responses.
human non-human primate
gene iD r(i) gene iD r(i)
V-DXP4-JH6c 24.7 IGHV-III VH26 10.29
IGKVJ 14.39 IGHV-II SESS 8.87
IGVH1 12.43 VPREB2 8.64
V-DK4-JH4b 12.33 IGKV-1 HK102 8.49
C-D-JH6 11.84 IGKV-11 RPMI6410 7.69
IGL 11.22 CD179b 7.57
IGK-3D-15 8.6 IGKV-1 HK101 6.17
IGLV2-23*01 8.2 KLRC1 6.16
MUC5AC 8.08 MMP3 5.81
NHPHL7 6.9 IGHV4-1 5.75
SCYB6 6.16 IGLV-I BL2 5.73
GRO1 6.1 ZLG 5.49
IGLJ3 6.03 PIP 5.41
TMEM156 5.89 IGLV-II MGC 5.2
IGHG3 5.78 IGHA2 5.19
PABL 5.42 FAM123A 5
KYNU 5.4 CLDN8 4.75
IL8 5.15 IGLV-III LOI 4.73
UBD 4.71 IGH 4.44
VNN1 4.62 IGJ 4.39
SLU7 4.19 ADCYAP1 4.37
IGKVJ 4.11 TVB2 CTL-L17 4.35
IGVH4 3.9 IGHV-II ARH-77 4.26
CPD 3.79 IGHV 4.26
PLAC8 3.51 POU2AF1 4.25
IGKVJC 3.49 APOE 4.23
SOD2 3.45 MCART6 4.15
IGK 3.34 IL19 4.13
IGLP3 3.27 hmRNPA1 4.12
CASP3 3.11 CXCL1 4.05
MS4A2 3.06 CCL20 4.05
CD20 3 IGLL1 4.04
MDM4 2.89 KLRF1 3.87
PLAT 2.87 COX6C 3.75
GLDC 2.81 HLA-DOB 3.7
CEACAM1 2.71 FAM30A 3.64
YES1 2.62 FOSB 3.57
PTH 2.53 CENPT 3.53
XBP1 2.49 SPATA4 3.52
FMO2 2.47 FAM46C 3.49
SOD2 2.45 IGL 3.43
PSME4 2.44 SPAST 3.39
SLC1A1 2.41 IGHG1 3.39
C20orf67 2.38 TNNI2 3.38
HS3ST1 2.38 LILRA1 3.38
CLCA4 2.34 IGLV-II BUR 3.38
GPR65 2.34 BANK1 3.37
PHLDA1 2.33 IGHV-I V35 3.36
HSP13A 2.16 IRF4 3.27
SLP76 2.15 TACI 3.27
IGA1C 2.13 IGK 3.26
Genes highlighted in yellow associated with adaptive immune responses.
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related to immunoglobulin heavy and light change rearrange-
ment and production. Only 6/25 plasmacyte-related genes were 
altered with periodontitis with all being increased in both adult 
and aged animals. Finally, a group of genes with multiple func-
tions in humoral immune responses are presented (Figure 3G) 
with 8/17 being altered, and only IL4 being consistently decreased 
in adult and aged periodontitis tissues.
Figure 4 provides a heatmap of the clustering of the B cell/
plasmacyte genes in healthy and periodontitis samples from 
adults and aged animals. The results provide a visualization of a 
cluster of genes that are clearly elevated in expression in healthy 
aged tissues and then increase substantially in periodontitis or 
more specifically, only in aged periodontitis tissues. Table 3 pro-
vides a summary of these gene expression changes identified with 
their primary gene functions. Six of the 26 gene alterations were 
related to antigen-dependent stimulation of the B cells, generally 
increasing sequentially from adult to aged healthy tissues and 
then continuing increased with adult to aged periodontitis tissues. 
The majority of changes were associated with differentiation/
maturation functions, particularly related to immunoglobulin 
diversity. The changes were noticeable in that the fold-increase 
approximately doubled from adult to aged healthy, and then the 
changes were threefold to sevenfold increased comparing healthy 
adult to periodontitis or healthy aged to periodontitis.
Since host-induced tissue destruction is a feature of the chronic 
inflammation of periodontitis, we explored the relationship 
between gingival expression of the B cell/plasmacyte group of 
genes and expression of genes associated with periodontal tissue 
destruction during health and periodontal disease irrespective of 
age. Included in these tissue destructive responses were evaluation 
of MMP2 (72 kDa type IV collagenase or gelatinase A active in 
extracellular matrix degradation and effects on integrins), MMP9 
(92 kDa type IV collagenase or gelatinase B, a regulatory factor in 
neutrophil migration and functions), CTSK (a lysosomal cysteine 
protease involved in bone remodeling and resorption, can cat-
abolize elastin, collagen, and gelatin), TNF (tumor necrosis factor 
alpha or cachexin is a cell signaling protein involved in systemic 
inflammation and contributes to the acute phase response with 
cell cytotoxic capabilities), and RANKL (receptor activator of 
nuclear factor kappa-B ligand also TNFSF11 is a principal fac-
tor in osteoimmunology linking the immune system and bone 
biology, as well as an apoptosis regulatory gene). The heatmap 
shows the correlations in either healthy or periodontitis samples 
of the B cell genes with the expression of tissue destructive genes 
(Figure  5) and provides an overview of the correlation of the 
B  cell/plasmacyte genes with the five tissue destructive genes 
in healthy and periodontitis tissues (adult and aged combined). 
Cluster 1 contained 15 genes showing a positive correlation with 
TNFα and negative correlation with MMP9, primarily in the 
periodontitis tissues. Cluster 2 genes (n =  12) were positively 
correlated with the expression of MMP2 and CTSK in both health 
and periodontitis, as well as with MMP9 only in periodontitis. 
Cluster 3 was a subset with 14 genes that negatively correlated 
with MMP2 in healthy samples and positively correlated with 
MMP9, RANKL, and CTSK in only the periodontitis samples. 
Cluster 4 contained 10 genes that were positively correlated with 
both MMP9 and CTSK in periodontitis. Cluster 5 genes (n = 34) 
showed a positive correlation with MMP9, RANKL, and CTSK in 
both healthy and periodontitis tissues, and a positive correlation 
with TNFα, but only in the healthy tissues. Cluster 6 contained 34 
genes with strong positive correlations with MMP9 and CTSK in 
both healthy and periodontitis tissues, and a negative correlation 
with TNFα in periodontitis. Cluster 7 grouped 28 genes with 
positive correlations to RANKL only in periodontitis tissues, 
TaBle 2 | alterations in gene expression in healthy gingival tissues 
related to gene functional categories.
gene functions Total 
genes
altered gene expression
Total Young adolescent aged
↑ or ↓ ↑ ↓ ↑ ↓ ↑ ↓
Antigen-dependent 
activation
38 10 0 6 1 3 8 0
B cell activation 18 4 0 1 0 0 3 3
B cell proliferation 33 6 0 2 0 2 5 0
Differentiation/
maturation
58 22 1 8 4 9 18 1
Plasmacyte 25 2 0 1 0 2 1 0
Multiple functions 17 3 0 2 0 2 1 0
↑ or ↓ denotes gene expression that was up- or downregulated compared with healthy 
adult tissues.
A B
FigUre 2 | Venn diagram depicting altered gene expression in healthy tissues (a) and periodontitis tissues (B) compared with levels in healthy adult 
tissues. Gene numbers denote fold differences by ≥1.5-fold. Naturally occurring periodontitis does not occur in younger age groups.
6
Ebersole et al. B Cell Responses in Mucosal Tissues of Periodontitis
Frontiers in Immunology | www.frontiersin.org July 2016 | Volume 7 | Article 272
and strong negative correlations to CTSK in periodontitis and 
MMP2 in both healthy and periodontitis samples. Cluster 8 
genes (n = 18) were similar to cluster 7 with negative correla-
tions to MMP2 and CTSK in periodontitis and health, as well 
as negative correlations with MMP9 in periodontitis tissues. 
Finally, cluster 9 genes (n = 8) were similar to expression pat-
terns for cluster 8, except for positive correlations with TNFα 
in periodontitis.
Table 4 summarizes the distribution of functional categories 
of the genes in each of these clusters and demonstrates some 
skewing of gene functions related to the various clusters of 
association with tissue destructive gene expression profiles. 
Clusters 1, 4, and 8 showed an expected general distribution 
across the functions. Cluster 3 showed an increased frequency 
of differentiation/maturation genes and decreased plasmacyte 
expression profiles. Clusters 4, 5, and 7 all exhibited increased 
proportions of the multiple function B cell genes. Cluster 6 was 
enriched for non-antigen-dependent B cell activation genes, 
whereas cluster 7 was depleted in this gene function. Finally, 
cluster 9, while containing a low number of genes was enriched 
for B cell proliferation genes, while being decreased for differ-
entiation/maturation genes.
DiscUssiOn
Dysregulation of multiple components of the immune system 
with aging contributes to increased prevalence and severity of 
infections and poses a challenge for prevention of infectious 
diseases via effective vaccination in aging populations. These 
dysfunctions have been described for adaptive immune B and 
T cells. Thus, aging individuals’ exhibit increased susceptibility 
to a number of inflammatory and degenerative pathologies. 
Included in this listing is an increased prevalence and severity 
of periodontitis, although the underlying causes remain poorly 
understood. The effects of aging on periodontal tissues have been 
suggested to be based on molecular changes in the array of cells 
of the periodontium, the combination of which is thought to 
intensify alveolar bone resorption in elderly individuals. These 
effects are considered to be reflective of (1) altered differentiation/
proliferation of cells for uncoupling bone biological processes 
(osteoblasts, osteoclasts); (2) enhanced responses to the oral 
microbiota, modified by environmental stressors leading to the 
secretion of cytokines/chemokines involved in osseous resorption; 
and (3) systemic endocrine alterations related to host responses 
and physiologic/pathologic bone responses with aging (53–56). 
Hajishengallis (57) proposed that an impaired modulation of the 
innate immune and inflammatory capacity of the host could also 
be associated with aging-related periodontitis. Nevertheless, less 
attention has been placed on the potential role of aging-related 
adaptive immunity changes that could be contributing to higher 
incidence and severity of periodontitis with aging. In general, 
most of the evidence is supported by studies demonstrating that 
innate immune and adaptive immune cells isolated from aged 
individuals exhibit intrinsic defects that could predispose the 
elderly to dysregulated immune and inflammatory responses 
underpinning the exacerbated clinical features of disease with 
AC D
E F
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B
 
FigUre 3 | (a–g) Gene expression profiles of periodontitis from adult (AD), aged (AG), and overall periodontitis (PD) group compared with levels in healthy adult 
tissues for each of the various B cell/plasmacyte functional categories.  
(Continued)
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TaBle 3 | gene expression differences in adult and aged healthy and periodontitis tissues related to average gene response patterns in healthy tissue 
samples from animals 3–7 years of age (correlates with 11- to 25-year-old human).
Fold difference
gene iD adult h aged h adult PD aged PD Fxn. categorya
CCR1 1.2 1.8 2.4 3.1 2
CD19 1.7 2.5 2.8 5.2 1
CD28 1.5 1.8 2.0 4.3 1
CD20 (MS4A1) 1.1 3.3 3.2 7.3 2.4
CR2 (CD21) 1.4 3.7 3.5 12.8 1
CTLA4 1.2 1.8 2.3 3.8 1
FOS 0.8 1.5 4.4 3.7 1
ICAM2 1.1 1.4 1.3 1.7 3
IGHG1 2.2 6.3 4.2 18.5 4
IGHM 2.5 7.4 12.2 16.9 4
IGHV2 ARH-77 1.6 2.4 5.1 10.8 4
IGHV3 VH26 1.3 1.8 3.2 7.1 4
IGHV4-1 0.9 1.8 3.2 8.5 4
IGJ 2.4 5.5 14.9 18.6 4
IGKC 1.3 2.9 2.1 10.4 4
IGKV1 HK102 3.1 4.1 14.6 27.9 4
IGLV2 BUR 2.6 5.5 10.9 15.5 4
IGLV3 LOI 3.0 6.7 14.6 28.7 4
IGLL1 1.9 3.7 5.4 11.5 4
IRF4 1.8 3.2 6.0 9.7 4
LRMP 1.2 1.5 2.1 3.3 3.4
POU2AF1 2.8 5.1 10.4 21.4 1
SELL 1.7 2.7 4.4 5.0 5
TNFRSF13B 1.4 2.1 2.5 4.0 2.4
TNFRSF17 3.0 5.8 9.6 22.3 4
VAV1 1.4 2.1 2.9 4.0 3
aFunctional categories denoted as 1 – antigen-dependent activation; 2 – cell activation; 3 – cell proliferation; 4 – differentiation/maturation; 5 – plasmacyte; 6 – multiple functions.
FigUre 4 | heatmap of fold differences in gene expression in adult and aged healthy and periodontitis tissues compared with response levels in 
healthy gingival tissues from a group of 10 animals 3–7 years of age (approximately 11- to 25-year-old humans). The bracket identifies a cluster of genes 
that were highly expressed in adult and aged tissues, particularly with periodontitis.
The bars denote the mean fold difference of disease from health. Only those genes with a fold difference ≥1.5 or ≤−1.5 in any of the three comparisons were 
included in the graph (21/38). The asterisk defines comparisons that were significantly different at least at p < 0.05.
FigUre 3 | continued
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aging. Integrated approaches examining cellular biology, animal 
models, and human studies of aging should contribute to tar-
geted molecular therapies that could mitigate the initiation and 
progression of periodontitis in aging and/or reverse the effects of 
aging on periodontitis as a chronic inflammatory disease.
The literature has clearly described the characteristics of 
the humoral adaptive immune response across gingival health 
toward various forms of periodontal disease with immuno-
globulins (antibodies) of all isotypes generally present at low 
levels in gingival crevicular fluid from healthy sites, minimizing 
TaBle 4 | Functional categories of genes in the various clusters of response profiles related to expression of a set of tissue destructive genes (TDgs).
cluster TDg profilea gene functional category
ag-dep. activation act. Prolif. Diff./Mat. Plasmacyte Multiple fxn
1 ↓9; ↑T 4 (3)b 1 (1) 2 (3) 4 (5) 3 (2) 1 (1)
2 ↑2; ↑C 0 (2) 1 (1) 3 (2) 4 (4) 2 (1) 2 (1)
PD: ↑9
3 PD: ↑9; ↑C; ↑R 4 (3) 2 (1) 2 (2) 6 (4) 0 (2) 0 (1)
H: ↓2
4 PD: ↑9; ↑C 1 (2) 0 (1) 0 (2) 4 (3) 2 (1) 3 (1)
5 ↑9; ↑C; ↑R 8 (7) 3 (3) 6 (6) 8 (11) 4 (4) 5 (2)
H: ↑T
6 ↑9; ↑C; ↓T 7 (7) 6 (3) 6 (6) 10 (11) 3 (4) 2 (2)
7 ↓2; ↑R; ↓C 5 (6) 1 (3) 5 (5) 10 (9) 5 (4) 4 (2)
8 ↓2; ↓C 5 (4) 2 (2) 2 (3) 5 (6) 3 (3) 1 (1)
PD: ↓9
9 ↓C 3 (2) 0 
(1)
3 (1) 1 (3) 1 (1) 0 (1)
PD: ↓9; ↑T
H: ↓2
aTDG profile denotes ↑, positive correlation; ↓, negative correlation; 2 – MMP2; 9 – MMP9; C – CTSK; R – RANKL; T – TNFα. H denotes only in healthy tissues, and PD denotes only 
in periodontitis tissues.
bNumbers denote frequency of genes observed in individual clusters and number of genes expected based on total genes representing that function (parentheses).
Those highlighted in bold indicate altered distribution.
FigUre 5 | heatmap depicting the distribution of correlations of B cell/plasmacyte genes with tissue destructive genes (MMP2, MMP9, cTsK, TnF, 
and ranKl) in healthy gingival tissues (h, n = 23) and periodontitis tissues (PD, n = 11) of adult and aged animals. The graph displays differences in 
gene expression in the adult and aged tissues compared with control levels displayed in a group of 10 healthy animals from 3 to 7 years of age. Green denotes 
negative correlation and red denotes positive correlation with the expression of the tissue destructive genes. The brackets signify the nine gene clusters created 
based on similarity indices of 0.4–0.5.
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the potential for various hypersensitivity reactions that could 
contribute to local tissue destruction. There is also a wealth of 
literature supporting the existence of local specific antibody 
production by plasma cells present in inflamed tissues of the 
periodontal pocket because levels of local antibody can be sig-
nificantly greater than those in the serum (19, 58, 59). However, 
the conundrum of existing data is why there appears to be a coin-
cidence of chronic oral infection with accompanying periods of 
exacerbated disease and an active, often substantial specific local 
and systemic immune response in periodontitis (19, 22). At pre-
sent, with our current level of knowledge, the true significance 
and function of the adaptive immune response under normal 
circumstances remains to be elucidated, let alone how aging 
specifically modulates the effectiveness of these responses.
Numerous alterations in B cells occur with aging (60–62). 
A critical aspect of B-lymphocytes is the heterogeneity of the 
10
Ebersole et al. B Cell Responses in Mucosal Tissues of Periodontitis
Frontiers in Immunology | www.frontiersin.org July 2016 | Volume 7 | Article 272
stimulated mature plasmacytes differing in terms of the anti-
genic specificity of their resulting antibody-combining sites. 
Dunn-Walters and Ademokun (63) have suggested that one 
consequence of aging effects on the humoral immune system 
is an altered B-cell diversity; however, how this process occurs 
which remains unclear. Various studies have identified possible 
differences in lymphocyte subpopulations across the lifespan that 
has been proposed to contribute to the onset of age-related vari-
ations of the adaptive immune responses (64–66), such that the 
in situ environments in old age are considered to be (1) reduced 
in B-cell generation and (2) altered in the readout of the antibody 
repertoire. Riley (64) has suggested that in old age B cell develop-
ment may progressively be diverted into a pre-BCR compromised 
pathway. While substantial literature is available over the last 
40 years documenting levels of serum, gingival crevicular fluid, 
and salivary antibody to oral bacteria as they relate to periodon-
titis (19, 22), evidence is sparse regarding how these antibody 
responses are regulated with aging (22). However, early studies 
of these responses that implied an increase in antibody levels 
with age, really did not effectively distinguish the effect of aging 
directly on the immune response system versus response profiles 
that reflected increased extent and severity of periodontitis, e.g., 
oral infection, with aging (67).
The prevalence and severity of periodontitis, including miss-
ing teeth, increase significantly with age in various species of 
non-human primates (49, 68, 69), and the disease is associated 
with antibody responses in this animal model to a battery of oral 
bacteria, including periodontal pathogens (49). We have evaluated 
various aspects of cellular gene expression that would contribute 
to adaptive immune responses in gingival tissues using this 
non-human primate model of periodontitis, including antigen-
presenting cells (70–72), characteristics of macrophage footprints 
in healthy and periodontitis gingival tissues from animals across 
their lifespan, as well as plasticity of the macrophage population 
in gingival tissues (73), and related to T cell phenotype/function 
during the initiation and progression of periodontitis related 
these to the expression of soft and bone tissue destruction genes 
(74).
This study extended these findings to the level of B cells and 
plasmacyte gene expression profiles with aging and periodontitis 
in this human-like animal disease model. While substantial 
research has developed focusing on innate immune and inflam-
matory molecular mechanisms of periodontitis (28, 57, 75, 76), 
we observed that within the upregulated transcriptome of both 
humans and non-human primates with periodontitis 40–60% of 
these genes were related to adaptive immune responses. These 
findings defined that, in fact, we still have a substantial gap in 
understanding the molecular events of adaptive immunity 
occurring in diseased gingiva that must play a critical role in 
the progression and/or resolution of the disease. Evaluation of 
transcriptomic footprints of B cells and plasmacytes provided a 
new view of patterns in healthy aging. First, a number of genes 
associated with the function of these cells were upregulated in 
healthy aged tissues, whereas an increased number of genes were 
significantly downregulated in healthy tissues from younger 
animals. These altered genes were primarily associated with what 
would be predicted to be an upregulation of B cell activation, 
proliferation, and differentiation/maturation processes occur-
ring in the healthy aged tissues. Approximately 1/3 of the B cell/
plasmacyte genes in healthy tissues were positively correlated 
with MMP9 expression levels across all of the functional classes 
of the B cell/plasmacyte genes, and approximately 1/2 of the 
genes in periodontitis were positively correlated with expression 
of this tissue altering enzyme. Results with CTSK responses 
showed a similar prevalence of positive correlations in healthy 
and periodontitis tissues, while a cluster of genes were negatively 
correlated with CTSK primarily in the periodontitis tissues. The 
patterns of responses related to RANKL showed that three of the 
clusters of B cell genes were generally positively correlated with 
RANKL, while only Cluster 5 was positively correlated in healthy 
tissues. High numbers of B cell/plasmacyte genes were also 
positively correlated with TNFα responses in the healthy tissues, 
focusing the most elevated levels in antigen-dependent activation 
genes. Summarizing these findings supported that increased B 
cell-related gene changes are observed in healthy aging tissues 
and that in healthy tissues (irrespective of age), generally B cell/
plasmacyte-associated gene expression positively correlated with 
levels of expression of various tissue destructive biomolecules. 
An interpretation of these findings is that with healthy aging an 
increase in tissue destructive gene expression, as we have recently 
reported (77), is balanced by an active B cell-related response 
profile that enhances the likelihood of maintaining homeostasis 
of these mucosal tissues even with the overall impact of aging on 
the immune response system.
These findings contrasted with periodontitis tissues where 
upregulated genes in aging periodontitis tissues were often two 
times greater than the level expressed in adult periodontitis, with 
nearly complete overlap. Approximately 40–60% of the antigen-
dependent activation, B cell activation, B cell proliferation, 
and B cell differentiation/maturation genes were altered with 
periodontitis, generally being increased in both adults and aged 
animals. Numerous genes related to immunoglobulin heavy and 
light change rearrangement and production (IGHG1, IGHM, 
IGHV2, IGHV3, IGHV4, IGJ, IGKC, IGKV1, IGLV2, IGLV3, 
and IGLL1) were substantially upregulated with the highest fold 
increases in aged animals with periodontitis. Additionally, com-
plement receptor 2 (CR2, Epstein–Barr virus receptor, CD21), 
POU domain class 2-associating factor 1 (POU2AF1), and 
TNFRSF17 [B-cell maturation antigen (BCMA); tumor necrosis 
factor receptor superfamily member 17] were increased in aged 
periodontitis approximately10-fold compared with healthy adult 
tissues. CR2 is on mature B cells and engages with membrane 
associated CD19 and CD81 leading to a complex called the B 
cell coreceptor complex (78–80). CR2 binds to antigens through 
attached C3d when the B cell membrane IgM binds to specific 
antigen. This antigen-specific binding results in B cells having a 
substantially elevated response to the antigen and, thus, enabling 
the complement system to play a role in B-cell activation and 
maturation. POU2AF1 codes for a transcriptional coactiva-
tor, Obf1 (Bob.1) that specifically associates with either OCT1 
(POU2F1) or OCT2 (POU2F2). It functions as a critical factor to 
accentuate OCT1- and OCT2-mediated promoter activation of 
immunoglobulin gene expression (81–83). It is essential, as part 
of the B cell receptor signaling pathway, for the response of B-cells 
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to antigens and required for the formation of germinal centers 
(84, 85). TNFRSF17 is a member of the TNF receptor superfamily 
and binds B cell activating factor (BAFF; TNFSF13B), which is 
expressed in B lineage cells resulting in potent B cell activation, 
as well as NF-κB and MAPK8/JNK activation (86, 87). It is pref-
erentially expressed on mature B cells and ligand engagement 
contributes to proliferation and differentiation of the B cells (78, 
88). This receptor also binds to various TRAF family members 
(TNF receptor-associated factors) that interact with inhibitor-
of-apoptosis proteins (IAPs) driving anti-apoptotic signals 
contributing to cell survival and proliferation (89, 90). These 
biomolecules and their associated pathways may provide novel 
targets for better understanding of the local adaptive immune 
response to the microbial insult that occurs with periodontitis.
Various discussions regarding the role of adaptive immunity, 
and particularly humoral immune responses in the development 
or protection from periodontitis have occurred over the decades, 
with some consistency in findings regarding antibody levels 
being increased with disease (22). However, a summation of the 
available literature from human studies regarding aging effects 
on humoral immune responses to oral microorganisms suggests 
rather minimal evidence to either support or refute that aging 
directly affects the capacity of individuals to mount an adaptive 
immune response to bacteria comprising the autochthonous 
oral microbiome including those associated with periodontitis. 
This report describes studies that emphasize a rather extensive 
alteration in the gingival environment with regard to B cell and 
plasmacyte activities in this non-human primate model of peri-
odontitis and suggest changes that occur in healthy tissues, with 
aging, as well as extensive alterations associated with naturally 
occurring disease. How these responses are driven by changes in 
the microbiome of subgingival biofilms with disease and processes 
that may occur with adaptive immune responses to control the 
infection and reestablish homeostasis remains to be determined.
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